Department of Biomedical Engineering, Cornell University, Ithaca, NY 14853, USA.
Annu Rev Biomed Eng. 2013;15:29-53. doi: 10.1146/annurev-bioeng-071811-150028. Epub 2013 Apr 29.
Heterogeneous microenvironmental conditions play critical roles in cancer pathogenesis and therapy resistance and arise from changes in tissue dimensionality, cell-extracellular matrix (ECM) interactions, soluble factor signaling, oxygen as well as metabolic gradients, and exogeneous biomechanical cues. Traditional cell culture approaches are restricted in their ability to mimic this complexity with physiological relevance, offering only partial explanation as to why novel therapeutic compounds are frequently efficacious in vitro but disappoint in preclinical and clinical studies. In an effort to overcome these limitations, physical sciences-based strategies have been employed to model specific aspects of the cancer microenvironment. Although these strategies offer promise to reveal the contributions of microenvironmental parameters on tumor initiation, progression, and therapy resistance, they, too, frequently suffer from limitations. This review highlights physicochemical and biological key features of the tumor microenvironment, critically discusses advantages and limitations of current engineering strategies, and provides a perspective on future opportunities for engineered tumor models.
异质的微环境条件在癌症的发病机制和治疗耐药性中起着关键作用,其产生源于组织维度的变化、细胞-细胞外基质(ECM)相互作用、可溶性因子信号、氧和代谢梯度以及外源性生物力学线索。传统的细胞培养方法在模拟生理相关性方面受到限制,只能部分解释为什么新型治疗化合物在体外通常有效,但在临床前和临床研究中却令人失望。为了克服这些限制,人们采用了基于物理科学的策略来模拟癌症微环境的特定方面。尽管这些策略有希望揭示微环境参数对肿瘤起始、进展和治疗耐药性的贡献,但它们也经常受到限制。本文重点介绍了肿瘤微环境的物理化学和生物学关键特征,批判性地讨论了当前工程策略的优缺点,并对工程肿瘤模型的未来机遇提供了展望。